Stevens-Johnson syndrome progressing to toxic epidermal necrolysis with haloperidol and carbamazepine combination
- PMID: 23271869
- PMCID: PMC3530283
- DOI: 10.4103/0972-6748.102517
Stevens-Johnson syndrome progressing to toxic epidermal necrolysis with haloperidol and carbamazepine combination
Abstract
Carbamazepine and other anticonvulsants are commoner cause of severe adverse cutaneous drug reactions such as erythema multiforme, toxic epidermal necrolysis (TEN), and Stevens-Johnson syndrome (SJS). We report a case of SJS rapidly progressing to TEN with a combination of haloperidol and carbamazepine in a patient with bipolar affective disorder. The pathophysiological mechanism underlying this reaction is discussed.
Keywords: Carbamazepine; Stevens–Johnson syndrome; haloperidol; toxic epidermal necrolysis.
Conflict of interest statement
Figures
References
-
- Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129:92–6. - PubMed
-
- Devi K, George S, Criton S, Suja V, Sridevi PK. Carbamazepine-the commonest cause of toxic epidermal necrolysis and Stevens-Johnson syndrome: A study of 7 years. Indian J Dermatol Venereol Leprol. 2005;71:325–8. - PubMed
-
- Roujeau JC, Stern RS. Severe Adverse Cutaneous Reactions to drugs. N Engl J Med. 1994;331:1272–85. - PubMed
-
- Summary of product characteristics. Haloperidol. [Last accessed on 2010 Mar 20]. Available from: http://emc.medicines.org.uk/medicine/17426/SPC/Haldol 10mg Tablets/
-
- Wong KE. Stevens-Johnson syndrome in neuroleptic-carbamazepine combination. Singapore Med J. 1990;31:432–3. - PubMed
